OPRX

B.Riley Financial analyst Marc Wiesenberger maintained a Buy rating on OptimizeRx (OPRX - Research Report) today and set a price target of $37.00. The company's shares opened today at $15.80.According to TipRanks, Wiesenberger is a 5-star analyst with an average return of 12.7% and a 44.03% success rate.The word on The Street in general, suggests a Strong Buy analyst consensus rating for OptimizeRx with a $25.83 average price target, a 63.48% upside from current levels. In a report released on October 31, Stifel Nicolaus also initiated coverage with a Buy rating on the stock with a $19.00 price target.
https://www.tipranks.com/news/blurbs/optimizerx-oprx-gets-a-buy-from-b-riley-financial?utm_source=advfn.com&utm_medium=referral